Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03922555
Title ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

high grade glioma

Therapies

Decitabine and Cedazuridine

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST